Matthew L. Sherman
2012 - Acceleron Pharma
In 2012, Matthew L. Sherman earned a total compensation of $598.1K as Executive Vice President and Chief Medical Officer at Acceleron Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $109,281 |
|---|---|
| Option Awards | $124,550 |
| Salary | $364,270 |
| Total | $598,101 |
Sherman received $364.3K in salary, accounting for 61% of the total pay in 2012.
Sherman also received $109.3K in non-equity incentive plan and $124.6K in option awards.
Rankings
In 2012, Matthew L. Sherman's compensation ranked 8,138th out of 11,487 executives tracked by ExecPay. In other words, Sherman earned more than 29.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,138 out of 11,487 | 29th |
Division Manufacturing | 2,943 out of 4,253 | 31st |
Major group Chemicals And Allied Products | 779 out of 1,203 | 35th |
Industry group Drugs | 557 out of 925 | 40th |
Industry Biological Products, Except Diagnostic Substances | 90 out of 165 | 46th |
Source: SEC filing on April 17, 2015.
Sherman's colleagues
We found four more compensation records of executives who worked with Matthew L. Sherman at Acceleron Pharma in 2012.